Skip Navigation

Cardiovascular Research 2000 47(3):549-555; doi:10.1016/S0008-6363(00)00102-4
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hung, L.-M.
Right arrow Articles by Su, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hung, L.-M.
Right arrow Articles by Su, M.-J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes

Li-Man Hunga, Jan-Kan Chenb, Shiang-Suo Huanga, Ren-Shen Leec and Ming-Jai Sua,*

aInstitute of Pharmacology, College of Medicine, National Taiwan University, No. 1, Sec. 1, Jen-Ai Road, Taipei, Taiwan
bDepartment of Physiology, College of Medicine, Chang Gung University, Taoyuan, Taiwan
cCenter of General Studies, Chang Gung University, Taoyuan, Taiwan

* Corresponding author. Tel.: +886-2-2356-2221; fax: +886-2-2391-5602 mjsu{at}ha.mc.ntu.edu.tw

Background: The major objective of the present study was to examine the cardioprotective effect of resveratrol, an antioxidant presents in red wines, in the rat after ischemia and ischemia–reperfusion (I–R). Methods: The left main coronary artery was occluded for 30 or 5 min followed by a 30-min reperfusion in anesthetized rats. Animals were preinfused with and without resveratrol before occlusion and the severity of ischemia- and I–R-induced arrhythmias and mortality were compared. Results: Resveratrol pretreatment had no effect on ischemia-induced arrhythmias nor on mortality. In contrast, a dramatic protective effects were observed against I–R-induced arrhythmias and mortality. Resveratrol pretreatment both reduced the incidence and duration of ventricular tachycardia (VT) and ventricular fibrillation (VF). During the same period, resveratrol pretreatment also increased nitric oxide (NO) and decreased lactate dehydrogenase levels in the carotid blood. Conclusions: Resveratrol is a potent antiarrhythmic agent with cardioprotective properties in I–R rats. The cardioprotective effects of resveratrol in the I–R rats may be correlated with its antioxidant activity and upregulation of NO production.

KEYWORDS Arrhythmia, mechanisms; Free radicals; Ischemia; Nitric oxide; Reperfusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. H. Choi, J.-E. Kim, N. R. Song, J. E. Son, M. K. Hwang, S. Byun, J. H. Kim, K. W. Lee, and H. J. Lee
Phosphoinositide-3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells
Cardiovasc Res, November 23, 2009; (2009) cvp359v2.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Csiszar, M. Wang, E. G. Lakatta, and Z. Ungvari
Inflammation and endothelial dysfunction during aging: role of NF-{kappa}B
J Appl Physiol, October 1, 2008; 105(4): 1333 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Venkatachalam, S. Mummidi, D. M. Cortez, S. D. Prabhu, A. J. Valente, and B. Chandrasekar
Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2078 - H2087.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Szkudelski
Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: evidence for pivotal role of metabolic disturbances
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E901 - E907.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. W. E. Rush, J. Quadrilatero, A. S. Levy, and R. J. Ford
Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats
Experimental Biology and Medicine, June 1, 2007; 232(6): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Sedding and J. Haendeler
Do We Age on Sirt1 Expression?
Circ. Res., May 25, 2007; 100(10): 1396 - 1398.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Das, A. Tosaki, D. Bagchi, N. Maulik, and D. K. Das
Potentiation of a Survival Signal in the Ischemic Heart by Resveratrol through p38 Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1/cAMP Response Element-Binding Protein Signaling
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 980 - 988.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
A. KASDALLAH-GRISSA, B. MORNAGUI, E. AOUANI, M. HAMMAMI, N. GHARBI, A. KAMOUN, and S. EL-FAZAA
PROTECTIVE EFFECT OF RESVERATROL ON ETHANOL-INDUCED LIPID PEROXIDATION IN RATS
Alcohol Alcohol., May 1, 2006; 41(3): 236 - 239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. K. Das and N. Maulik
Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
Mol. Interv., February 1, 2006; 6(1): 36 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Das, A. Tosaki, D. Bagchi, N. Maulik, and D. K. Das
Resveratrol-Mediated Activation of cAMP Response Element-Binding Protein through Adenosine A3 Receptor by Akt-Dependent and -Independent Pathways
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 762 - 769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Das, G. A. Cordis, N. Maulik, and D. K. Das
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H328 - H335.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. PERVAIZ
Resveratrol: from grapevines to mammalian biology
FASEB J, November 1, 2003; 17(14): 1975 - 1985.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
P. Boscolo, A. d. Signore, E. Sabbioni, M. Di Gioacchino, L. Di Giampaolo, M. Reale, P. Conti, R. Paganelli, and M. Giaccio
Effects of Resveratrol on Lymphocyte Proliferation and Cytokine Release
Ann. Clin. Lab. Sci., April 1, 2003; 33(2): 226 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Gao, Y. X. Xu, G. Divine, N. Janakiraman, R. A. Chapman, and S. C. Gautam
Disparate In Vitro and In Vivo Antileukemic Effects of Resveratrol, a Natural Polyphenolic Compound Found in Grapes
J. Nutr., July 1, 2002; 132(7): 2076 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Hattori, H. Otani, N. Maulik, and D. K. Das
Pharmacological preconditioning with resveratrol: role of nitric oxide
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1988 - H1995.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Imamura, A. A. Bertelli, A. Bertelli, H. Otani, N. Maulik, and D. K. Das
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1996 - H2003.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. O. Cheng, L. M. Blanco-Colio, C. Bustos, M. Ortego, M. A. Hernandez-Presa, P. Cancelas, J. Gomez-Gerique, J. Egido, M. Valderrama, L. A. Alvarez-Sala, et al.
Conundrum of the "French Paradox" Response
Circulation, June 26, 2001; 103 (25): e132 - e133.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.